Dr Emer MacSweeney, CEO of Re:Cognition, delves into the new era of Alzheimer’s care
The NHS stands at a crossroads. After 76 years as the jewel in Britain’s crown, it continues to be regarded internationally as a symbol of excellence and compassion. But like other state-based healthcare systems, it also faces unprecedented pressures such as rising patient demand, workforce shortages, crumbling infrastructure and stretched finances. Within these challenges lies an extraordinary opportunity that has remained largely untapped – the potential to attract strategic international investment that could help secure the NHS’s future whilst staying true to its founding principles.
Maximising this opportunity forms the basis of a new white paper, Advancing Inward Investment into the UK Health Sector, published by Browne Jacobson and Healthcare World. Insights were developed following two roundtable sessions that brought together NHS leaders, policymakers, legal experts and representatives from the private sector. The report examines how Britain’s most treasured institution could leverage its global reputation to attract ‘smart money’ – investment that goes beyond simple financial contributions to bring expertise, innovation and transformative partnerships.
This initiative comes at a pivotal moment after the government published its 10-year health plan for the NHS and modern industrial strategy, both of which recognise healthcare as a critical sector for national competitiveness and economic growth. The white paper’s eight recommendations provide a practical roadmap for increasing inward investment into the UK healthcare sector in a mutually beneficial way. Encouraging these partnerships will not only address the NHS’s immediate needs but also lay the foundations for long-term growth and sustainability.
Disentangling a fragmented NHS
The statistics paint a stark picture. The NHS employs more than 1.7m people and serves 66m patients, making it one of the world’s largest employers and healthcare systems. Its global reputation remains formidable — the NHS brand is recognised internationally as a symbol of quality, equity and innovation. Yet this potential remains largely unrealised when it comes to attracting the kind of strategic partnerships that could help address systemic challenges.
“Inward investment is not just about profit; it’s about leveraging resources to strengthen our people, organisations and technologies,” says Jyoti Mehan, CEO of Healthcare First.
The current landscape reveals significant barriers to engagement. With more than 1,400 procurement frameworks managed by NHS trusts and integrated care boards, the system is highly fragmented. International investors and suppliers, particularly SMEs, often find the complexity overwhelming. This fragmentation isn’t just an administrative headache; it’s actively deterring the kind of innovation partnerships that could help the NHS tackle its biggest challenges.
Several recommendations proposed in the white paper seek to address these challenges. The experts agreed that the Department of Health and Social Care, working with the NHS, must provide clear guidance to investors via an interactive inward investment toolkit for use at international conferences. Available in multiple languages, it should signal specific clinical and geographical priorities while minimising focus on lower-priority areas.
If this guide is in the shop window, a new ‘NHS front door’ that acts as a single, centralised entry point for foreign investors would open clear pathways into the UK healthcare market. A dedicated central business development unit, which manages trade and investment engagement, would maximise returns from NHS partnerships by ensuring these achieve economies of scale.
A new approach to partnership
The research calls for what it describes as ‘smart money’ — investment directed toward mutual benefit, shared revenue, measurable social impact, and reinvestment in national priorities. This concept isn’t about privatisation or profiteering, but about creating sustainable collaborations that enhance NHS capacity and outcomes while aligning with broader national objectives.
The NHS offers unique assets that international partners find attractive, such as universal health coverage, extensive health data resources, world-leading research capabilities and a commitment to innovation. The challenge is creating clear pathways for engagement that benefit all parties.
“We’ve been selling the NHS the same way we did five years ago before the pandemic, but our strategy must change to attract foreign direct investment,” says Dace Dimza-Jones, inward investment specialist at the Department for Business and Trade. “It needs to be much more dynamic.”
Brexit has complicated matters, with regulatory complexities and the loss of EU market access reducing the UK’s attractiveness as a European gateway. Tom Elliott, CEO of Medilink, notes the stark reality: “We used to work with hundreds of international SMEs investing in the UK, and that number has now reduced to double digits as the post-Brexit environment is making it less attractive for smaller companies.”
However, Brexit has also created opportunities. Post-Brexit regulatory freedoms could allow for streamlined approval pathways for medical technology and digital health innovations, positioning the UK as a leader in emerging healthcare technologies.
The digital opportunity
Perhaps nowhere is the potential more evident than in HealthTech and MedTech. Vast data assets within the NHS represent an unparalleled opportunity for innovation, but they remain largely siloed across different care settings. The integration of artificial intelligence, digital therapeutics and advanced medical devices could revolutionise healthcare delivery, but only if the regulatory and procurement frameworks can adapt to support these innovations.
The white paper argues for a comprehensive health data strategy that unlocks the value of NHS data assets while maintaining stringent privacy and ethical standards.
Workforce as investment
One of the most innovative aspects of the research is its recognition of foreign-trained healthcare professionals as a form of inward investment. With a quarter of NHS staff made up of foreign nationals, these practitioners represent not only a response to workforce shortages but also a strategic asset, bringing global expertise and diverse perspectives.
However, the current approach to international recruitment lacks the strategic framework needed to maximise this investment. Brexit’s impact on the mutual recognition of professional qualifications has complicated matters, requiring new approaches to credential recognition and cultural integration.
The research suggests viewing international healthcare professionals as ‘people as investment’, requiring comprehensive support systems, streamlined qualification processes and cultural integration programmes that help them contribute fully to NHS operations and strategic goals.
Regional innovation and national co-ordination
Successful regional initiatives show what can be achieved when the right support structures are in place. Yorkshire and Humber’s Propel@YH digital health accelerator has fostered innovation by supporting SMEs and international companies with mentorship and resources. Similarly, Leeds Teaching Hospitals NHS Trust’s Innovation Pop-Ups provide direct collaboration opportunities between healthcare providers and international companies.
These programmes have delivered tangible results, including the adoption of mixed-reality tools for pre-surgical education and virtual rehabilitation therapies. However, their impact remains limited by the lack of national co-ordination and integration with broader strategic objectives.
“A central resource to pragmatically enable provider organisations within the NHS to work in the international commercial space is essential,” notes Ged Byrne, international director at NHS England. “Many are willing to enter partnerships with investors or exporters but are inhibited by a lack of technical knowledge.”
The path forward
The white paper’s eight recommendations provide a comprehensive framework for transforming the NHS’s approach to international investment. Ranging from new marketing materials and the creation of an ‘NHS front door’ for investors to addressing legal barriers through revised procurement processes and establishing a structured investment framework, the plan will require a coordinated strategy led by government in partnership with the NHS.
The timing is critical. With innovation at the bedrock of the 10-year health plan and modern industrial strategy, there is an opportunity to position healthcare as a cornerstone of Britain’s economic future.
The global reputation of the NHS, combined with the UK’s research excellence and regulatory expertise, creates a unique proposition for international partners.
The question isn’t whether the NHS needs international investment – it’s whether Britain can create the frameworks needed to attract the right kind of partnerships. The white paper provides a roadmap, but implementation requires political will, stakeholder buy-in and a shared commitment to ensuring investment serves the public interest.
CONTACT INFORMATION
www.recognitionhealth.com